Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2022
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast CancerQiongyu Hao, Zhimin Huang, Qun Li, et al.Science China. Life Sciences|July 27, 2025
Multi-omic-based classification for identifying optimal neoadjuvant treatment strategies for high-risk early-stage breast cancerFei Ji, Xianzhe Chen, Ciqiu Yang, et al.International Journal of Cancer|September 30, 2021
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trialLiulu Zhang, Zhi-Yong Wu, Jie Li, et al.Annals of Internal Medicine|March 23, 2026
Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain : A Prospective, Randomized, Phase 3 TrialPeiyong Li, Yitian Chen, Yingyi Lin, et al.Cell Death & Disease|December 14, 2020
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNAQiongyu Hao, Piwen Wang, Pranabananda Dutta, et al.Scientific Reports|May 20, 2020
Author Correction: The Genome Sequences of 90 MushroomsHuiying Li, Surui Wu, Xiao Ma, et al.Scientific Reports|July 4, 2018
The Genome Sequences of 90 MushroomsHuiying Li, Surui Wu, Xiao Ma, et al.Ebiomedicine|June 22, 2021
DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutationsMei Yang, Yanhui Fan, Zhi-Yong Wu, et al.Pageof 7